1. Package insert for Mometasone Nasal 50 μg [MYL] 56 sprays and 112 sprays. https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/480115_1329710Q3020_1_03. Accessed 3 Nov 2021 (In Japanese).
2. Gotoh M, Sugita K, Saito A, et al. A study of the therapeutic equivalence of generic vs mometasone nasal spray in patients with seasonal allergic rhinitis. Jpn J Rhinol. 2018;57:7–16.
3. MHLW. Guideline for Bioequivalence Studies of Generic Products for Topical Use. http://www.nihs.go.jp/drug/be-guide(e)/Topical_BE-E.pdf. Accessed 7 Nov 2021.
4. MHLW. Basic Principles on Bioequivalence Evaluation of Generic Dry Powder Inhalers. https://www.nihs.go.jp/drug/be-guide(e)/Powder%20Inhalers.pdf. Accessed 24 Dec 2021.
5. MHLW. Basic Principles on Bioequivalence Studies of Generic Ophthalmic dosage forms. https://www.nihs.go.jp/drug/be-guide(e)/Ophthalmic%20dosage%20forms.pdf. Accessed 24 Dec 2021.